Collaborate Disseminate
As a new age of weight-loss therapeutics dawns, heralded by the likes of semaglutide (Ozempic, Wegovy), scientists are one step closer to creating a drug that can coax muscles into behaving as if they’ve just been put through a vigorous workout. Known … Continue reading Drug that mimics exercise triggers weight loss and builds lean muscle
There’s growing recognition that attention-deficit hyperactive disorder (ADHD) is not just a disruptive childhood condition, with conservative numbers estimating that 8.7 million adults in the US are living with it, both diagnosed and not. Yet older adults, aged 50 and over, are not only consistently absent from ADHD studies, but face roadblocks if they even try to seek help.
Tags: Örebro University, ADHD, Aging, Age-Related, Alzheimer’s Disease, Dementia, Cardiovascular
Continue reading Calls to address overlooked ADHD in adults aged 50 and over
Australian National University (ANU) physicists have combined nanotechnology, artificial intelligence and molecular biology to design a novel method that looks for Alzheimer’s disease protein markers in blood. These markers are tell-tale signs of early neurodegeneration, and early detection is so far the best defense we have in order to effectively intervene in Alzheimer’s progression. While there’s no cure for the disease, a 20-year jump on symptoms first appearing has the potential to significantly change health outcomes.
Tags: Australian National University, Alzheimer’s Disease, Dementia, Neuroscience, Multiple Sclerosis, Parkinson’s Disease, Nano, Nanotechnology, Artificial Intelligence, Machine Learning
Continue reading Simple test predicts Alzheimer’s risk, 20 years before symptoms show
A new study has found that people over 60 with untreated high blood pressure have a greatly increased risk of developing dementia compared to those who take blood pressure medication. The findings suggest that maintaining treatment for high blood press… Continue reading Untreated high blood pressure in over-60s increases dementia risk by 42%
The spice that can instantly stain an amateur chef’s kitchen benches, hands and clothes bright yellow has again shown it may be punching above its weight in other ways, with a clinical trial showing it can curb acid reflux as well as common medications… Continue reading Turmeric as effective for acid reflux as pharmacy drugs, trial shows
Scientists have discovered how a unique kind of cell death, due to iron toxicity, creates a snowball effect that advances cognitive decline. With this finding, a whole new approach to treatment could be developed.
Tags: Oregon Health and Science University, Alzheimer’s Disease, Dementia, Brain, Cells, Nerves, Neurological, Neuroscience
Continue reading Scientists uncover new pathway of Alzheimer’s disease progression
In an effort to find new treatments to halt the progression of Alzheimer’s disease, scientists at The Picower Institute for Learning and Memory at the Massachusetts Institute of Technology (MIT) have landed on a molecule that can improve memory by putting the brakes on a process that causes brain inflammation.
Tags: MIT, Alzheimer’s Disease, Dementia, Age-Related, Cells, molecular biology, Brain, Inflammatory
Continue reading New molecule slams the brakes on Alzheimer’s disease inflammation
Researchers have developed a new risk ‘calculator’ that identifies people in midlife at risk of developing dementia in the next 14 years, outperforming existing scores. Moreover, it’s based on 11 key risk factors, many of them modifiable.Continue Readi… Continue reading New “calculator” identifies 14-year dementia risk from 50 onwards
A new study has found that particular gastrointestinal disorders are associated with an increased risk of developing Parkinson’s disease. The research provides further evidence to support the hypothesis that the neurodegenerative disorder begins in the gut.
Tags: Parkinson’s Disease, Mayo Clinic, Neurological, Dementia
Continue reading Four gut disorders associated with increased Parkinson’s risk
Questions have been raised after the US Food and Drug Administration (FDA) recently fast-tracked its approval of brexpiprazole (Rexulti), an antipsychotic for treating agitation in dementia patients, when clinical studies demonstrated an increased risk… Continue reading FDA rushes approval of dementia drug that quadruples risk of death